Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 5, 2005

View Archived Issues

Gedeon Richter and Forest Laboratories collaborate on CNS compounds

Phenoxodiol with docetaxel studied for recurrent ovarian cancer

Bristol-Myers Squibb identifies a new inhibitor of HsEg5, an attractive target for cancer

New anti-TNF immunotherapy from Abgenix

OMX-2: cytostatic agent for brain tumor therapy

Sterix's new anticancer candidates

PRO-140 enters phase Ib study in HIV

Astellas licenses rights for XP-13512 in Asia and Japan

Predix reaches agreement under SPA for PRX-00023

PRX-08066 begins phase Ib study for PAH

Imagenetix launches Celadrin/glucosamine product

Canadian sites to join ADAGIO study of Agilect

PIramed and Genentech collaborate to develop new class of anticancer drugs

ImmuFact IMP-321 studied for metastatic renal cell carcinoma

GlaxoSmithKline updates progress of oncology and supportive care compounds

Lexicon Genetics and Genentech expand drug discovery alliance

Clinical progress of a novel investigational anticancer drug BIBW-2992

FDA Advisory Committee to discuss Daytrana NDA

Procleix West Nile Virus Assay receives FDA approval

Priority review awarded to Taxotere sNDA in gastric cancer

Oncaspar sBLA accepted for review

Prostanoid EP4 receptor agonists emerge from Allergan R&D

Novel diagnostic agents disclosed in recent patents

Recent patents cover novel treatments for anxiety, depression, sleep disorders, etc.

Novel proteasome inhibitor compared to bortezomib against multiple myeloma

Antimitochondrial agent RH-123 offers promise in phase I prostate cancer trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...